Maxidex · DIN 00042579 · 0.1% · Oph Oint-3.5g Pk
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Maxidex · DIN 00042579
Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2018-01-19 · brand MAXIDEX · ATC S01BA01 DEXAMETHASONE · form Ointment · route Ophthalmic · ingredients DEXAMETHASONE 0.1 %/W/W · company Maag technic ag · schedule Prescription
Maxidex: Formulary list price $9.72 per unit (the source does not state the unit; exact figure $9.7200). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00042579)
Source record
DIN 00042579: Maxidex
Raw flags: sec3=Y
Item: 520800015; group id 592; item number 1550; lccId None; manufacturer id NOV
Source form: Oph Oint-3.5g Pk; strength: 0.1%
Recorded listing: General benefit
Source prices (unrounded): $9.7200; ministry $9.7200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00042579
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4591
Shortage status: not checked (no credentials)